GENE SIGNAL INTERNATIONAL SA Patent applications |
Patent application number | Title | Published |
20140134276 | ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF - A method for the treatment of cancers and/or tumors by administration of a polypeptide having the sequence SEQ ID NO:4 or a polypeptide having an amino acid SEQ ID NO Y which, when aligned with SEQ ID N: 4, has (a) a percentage of identical residues over SEQ ID NO: 4 length of at least 50%, and (b) a percentage of identical residues over a amino acid sequence SEQ ID NO Y length of at least 65% or fragments thereof having at least 20 contiguous amino acids. | 05-15-2014 |
20140134185 | Composition Comprising Inhibitors of IRS-1 and of VEGF - The present invention relates to a composition or kit of parts comprising an inhibitor of IRS-1 and an inhibitor of the VEGF pathway and to the use thereof for treating an angiogenic disease. | 05-15-2014 |
20140011858 | Inhibitor of IRS-1 for Treating Skin Disorders - The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease. | 01-09-2014 |
20130274202 | Peptides for Treating Cancer - The present invention relates to peptide from 4 to 50 amino acids comprising a phosphorylated pYX | 10-17-2013 |
20130157949 | Novel Peptides for Wound Healing - The present invention relates to new peptides, pharmaceutical composition and cosmetic composition comprising them and their use for wound healing. | 06-20-2013 |
20130004511 | COMPOSITION COMPRISING INHIBITORS OF IRS-1 AND OF VEGF - Compositions comprising an inhibitor of IRS-1 and an inhibitor of the VEGF pathway, which compositions rare useful for treating an angiogenic disease. The specification also relates to kits comprising an inhibitor of IRS-1 and an inhibitor of the VEGF pathway, as well as methods of treating angiogenic diseases using such compositions and/or kits. | 01-03-2013 |
20120157389 | PEPTIDES FOR TREATING CANCER - The present invention relates to peptide from 4 to 50 amino acids comprising a phosphorylated pYX | 06-21-2012 |
20120041047 | Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions - This invention relates to a pharmaceutical composition for the treatment and/or prevention of at least one pathological neovascularization-related conditions of the interior of the eye, the composition comprising a therapeutically effective amount of an antisense oligonucleotide having the sequence SEQ ID NO: 1: | 02-16-2012 |
20110306545 | NOVEL PEPTIDES FOR WOUND HEALING - The present invention relates to new peptides, pharmaceutical composition and cosmetic composition including them and their use for wound healing. | 12-15-2011 |
20110038951 | ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF - The present invention relates to an active polypeptide including the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO:2, variants and antigenic fragments thereof, SEQ ID NO 16 or SEQ ID NO 17. | 02-17-2011 |
20100151051 | ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF - An active polypeptide comprising the amino acid sequence of SEQ ID NO:4, having an anti-tumour activity, and compositions and methods including the active polypeptide. | 06-17-2010 |
20100047369 | ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF - An active polypeptide comprising the amino acid sequence of SEQ ID NO: 3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO: 3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO: 2. A method for inhibiting cancer and/or tumour growth comprising administering to a subject in need thereof an effective amount of the active polypeptide. | 02-25-2010 |
20080286381 | Anti-tumor drug, medicament, composition, and use thereof - An active polypeptide includes the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 20 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO:2. | 11-20-2008 |
20080254145 | Anti-tumor drug, medicament, composition, and use thereof - The present invention relates to an active polypeptide comprising the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO:2. | 10-16-2008 |
20080241210 | WOUND HEALING AGENT AND COMPOSITION - The present invention relates to a wound-treating agent and to a composition for the treatment of wounds comprising a polypeptide having the amino acid sequence of SEQ ID NO:2, or of a polypeptide having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:2. | 10-02-2008 |